New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Lexaria Bioscience Corp.
LEXX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

31M

Biotechnology

Next Earning date - 08 Apr 2025

31M

Biotechnology

Next Earning date - 08 Apr 2025

1.38USD

Shape0.01 ( 0.72%)
Market Closed (as of Mar 06, 21:00 EDT)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-53%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

69%

Quote Panel

Shape
Updated March 23, 2025
1W 20.41 % 1M 15.69 % 3M -19.91 % 1Y -55.19 %

Key Metrics

Shape
  • Market Cap

    31.07M


  • Shares Outstanding

    17.55M


  • Share in Float

    16.27M


  • Dividende

    0


  • Earning Date

    08 Apr 2025


  • Price Target

    1.77


  • Average Volume

    164353


  • Beta

    0.962


  • Range

    1.15-4.44


  • Industry

    Biotechnology


  • Website

    https://www.lexariabioscience.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

LEXX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$592K

Shape222%

2025-Revenue

$0.58

Shape-266%

2025-EPS

$592K

Shape78%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-07-10

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.22
vs -0.25

Q2.23

arrow
arrow

N/A

-0.37
vs -0.41

Q3.23

arrow
arrow

N/A

-0.12
vs -0.24

Q4.23

arrow
arrow

N/A

-0.13
vs -0.30

Q1.24

arrow
arrow

N/A

-0.06
vs -0.22

Q2.24

arrow
arrow

N/A

-0.13
vs -0.37

Q3.24

arrow
arrow

N/A

-0.15
vs -0.12

Q4.24

arrow
arrow

N/A

-0.16
vs -0.13

Q1.25

arrow
arrow

N/A

-0.15
vs -0.06

Q2.25

arrow
arrow

N/A

-0.14
vs -0.13

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-35%

20K  vs 30.6K

Q2.23

arrow
arrow

-7%

93.2K  vs 99.7K

Q3.23

arrow
arrow

-103%

-3433.00  vs 111.2K

Q4.23

arrow
arrow

+49%

151.3K  vs 101.5K

Q1.24

arrow
arrow

+624%

145K  vs 20K

Q2.24

arrow
arrow

-10%

84K  vs 93.2K

Q3.24

arrow
arrow

+2547%

84K  vs -3433

Q4.24

arrow
arrow

+22%

183.9K  vs 151.3K

Q1.25

arrow
arrow

+3%

150K  vs 145K

Q2.25

arrow
arrow

+79%

150K  vs 84K

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-26%

-0.26
vs -0.28

Q2.23

arrow
arrow

-54%

-0.54
vs -0.26

Q3.23

arrow
arrow

-41%

-0.41
vs -0.54

Q4.23

arrow
arrow

-32%

-0.32
vs -0.41

Q1.24

arrow
arrow

-10%

-0.10
vs -0.32

Q2.24

arrow
arrow

-18%

-0.18
vs -0.10

Q3.24

arrow
arrow

-27%

-0.27
vs -0.18

Q4.24

arrow
arrow

-28%

-0.28
vs -0.27

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

16

16
vs 16

NA

Q2.23

arrow
arrow

12

12
vs 16

-25%

Q3.23

arrow
arrow

14

14
vs 12

17%

Q4.23

arrow
arrow

19

19
vs 14

36%

Q1.24

arrow
arrow

25

25
vs 19

32%

Q2.24

arrow
arrow

28

28
vs 25

12%

Q3.24

arrow
arrow

27

27
vs 28

-4%

Q4.24

arrow
arrow

25

25
vs 27

-7%

Earnings Growth

Latest News